|

Patient-Derived Xenografts to Reduce Cancer Health Disparities

RECRUITINGSponsored by University of California, Davis
Actively Recruiting
SponsorUniversity of California, Davis
Started2019-11-12
Est. completion2026-12
Eligibility
Age21 Years – 100 Years
Healthy vol.Accepted
Locations2 sites

Summary

This trial establishes patient-derived cancer xenografts in addressing cancer health and treatment disparities that disproportionately affect racial/ethnic minorities. Understanding the genetic and response differences among racial/ethnic minorities may help researchers enhance the precision of therapeutic treatments.

Eligibility

Age: 21 Years – 100 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patient receiving treatment for the above 4 cancers (bladder cancer, lung cancer, gastric/stomach cancer, and liver cancer)
* Signed informed consent that will be put on file

Exclusion Criteria:

* No informed consent obtained
* Specimen unacceptable/degraded/etc.
* Individuals who are not yet adults (infants, children, teenagers)
* Pregnant women
* Prisoners
* Adults unable to consent

Conditions9

Bladder CarcinomaCancerGastric CarcinomaLiver CancerLiver DiseaseLiver and Intrahepatic Bile Duct CarcinomaLung CancerLung CarcinomaMalignant Neoplasm

Locations2 sites

UC Irvine Health/Chao Family Comprehensive Cancer Center
Orange, California, 92868
Marian Waterman949-824-2885marian.waterman@uci.edu
University of California Davis Comprehensive Cancer Center
Luis G. Carvajal-Carmona530-752-9654lgcarvajal@ucdavis.edu

Find trials near these locations

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.